LUDWIG INSTITUTE FOR CANCER RESEARCH: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- LUDWIG INSTITUTE FOR CANCER RESEARCH (EIN 23-7121131)
- Tax period
- 2022-01-01 to 2022-12-31
- Filed
- 2023-10-31
- IRS object ID
- 202343049349302314
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-10-31T17:03:00-05:00 | ReturnTs |
| Tax Period End | 2022-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PWC US TAX LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 300 MADISON AVENUE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10017 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 237121131 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Ludwig Institute for Cancer Research Ltd | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % URS KUNZ | InCareOfNm |
| Business Name Control | LUDW | BusinessNameControlTxt |
| Phone | 2124501500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 600 Third Avenue 32nd Floor | AddressLine1Txt |
| City | New York | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10016 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Edward A McDermott Jr | PersonNm |
| Person Title | President | PersonTitleTxt |
| Phone | 2124501500 | PhoneNum |
| Signature | 2023-10-26 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | Edward A | PersonFirstNm |
| Person Last | McDermott Jr | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | ERIC M MCNEIL | PreparerPersonNm |
| PTIN | P00460263 | PTIN |
| Phone | 2673303000 | PhoneNum |
| Preparation | 2023-10-20 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 3 | TrustedCustomerCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | Edward A McDermott Jr | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 600 Third Avenue 32nd Floor | AddressLine1Txt |
| City | New York | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10016 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $102,443,688 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.ludwigcancerresearch.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1971 | FormationYr |
| Legal Domicile Country | SZ | LegalDomicileCountryCd |
| Activity Or Mission | The Ludwig Institute for Cancer Research Ltd is a global non-profit institute committed to improving the under- standing & control of cancer through laboratory and clinical research. | ActivityOrMissionDesc |
| Voting Members Governing Body | 8 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 6 | VotingMembersIndependentCnt |
| Total Employee | 79 | TotalEmployeeCnt |
| Total Volunteers | 0 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $60,948,408 | PYContributionsGrantsAmt |
| CY Contributions Grants | $90,702,581 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $22,775,758 | PYInvestmentIncomeAmt |
| CY Investment Income | $3,836 | CYInvestmentIncomeAmt |
| PY Other Revenue | $5,540,542 | PYOtherRevenueAmt |
| CY Other Revenue | $11,737,271 | CYOtherRevenueAmt |
| PY Total Revenue | $89,264,708 | PYTotalRevenueAmt |
| CY Total Revenue | $102,443,688 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $25,102,163 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $24,298,963 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $2,549,735 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $64,927,081 | PYOtherExpensesAmt |
| CY Other Expenses | $83,570,734 | CYOtherExpensesAmt |
| PY Total Expenses | $90,029,244 | PYTotalExpensesAmt |
| CY Total Expenses | $107,869,697 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$764,536 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$5,426,009 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $25,811,385 | TotalAssetsBOYAmt |
| Total Assets EOY | $21,583,740 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $21,912,622 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $19,553,709 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $3,898,763 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $2,030,031 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | The Ludwig Institute for Cancer Research Ltd is an international not-for-profit organization committed to preventing and controlling cancer through integrated laboratory and clinical research. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $77,003,412 | ExpenseAmt |
| Desc | Laboratory research leading to clinical applications - see schedule O | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $7,128,876 | ExpenseAmt |
| Desc | Clinical research - see schedule O | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $84,132,288 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | false | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | false | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (true) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (true) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | false | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | false | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 46 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 79 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | BE | ForeignCountryCd |
| Foreign Country | SZ | ForeignCountryCd |
| Foreign Country | UK | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (true) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 8 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 6 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (true) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | Yes (true) | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (true) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | Yes (true) | LocalChaptersInd |
| Policies Reference Chapters | Yes (true) | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | URS KUNZ | PersonNm |
| Phone | 2124501500 | PhoneNum |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | LICR LTD STADELHOFERSTR 22 | AddressLine1Txt |
| City | ZURICH | CityNm |
| Country | SZ | CountryCd |
| Foreign Postal | CH-8001 | ForeignPostalCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (19 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Key EmployeeKeyEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| DR DON CLEVELAND | |||||||||
| GROUP LEADER | 45.0 | 0.0 | Yes (X) | $1,140,218 | $0 | $71,235 | |||
| DR CHI VAN DANG | |||||||||
| DIRECTOR, SCIENTIFIC DIRECTOR | 50.0 | 2.0 | $1,017,288 | $0 | $70,763 | Yes (X) | Yes (X) | ||
| EDWARD A MCDERMOTT JR | |||||||||
| DIRECTOR, PRESIDENT | 44.0 | 4.0 | $0 | $916,361 | $101,470 | Yes (X) | Yes (X) | ||
| DR RICHARD KOLODNER | |||||||||
| GROUP LEADER | 50.0 | 0.0 | Yes (X) | $877,903 | $0 | $75,621 | |||
| DR JONATHAN SKIPPER | |||||||||
| EXEC VICE-PRES TECH DEVELOP. | 45.0 | 0.0 | $766,905 | $0 | $71,877 | Yes (X) | |||
| DR BING REN | |||||||||
| GROUP LEADER | 45.0 | 0.0 | Yes (X) | $724,603 | $0 | $79,101 | |||
| DR RALPH VENHAUS | |||||||||
| CHIEF MEDICAL OFFICER | 50.0 | 0.0 | Yes (X) | $536,028 | $0 | $71,763 | |||
| THOMAS BAENNINGER | |||||||||
| CHIEF FINANCIAL OFFICER | 40.0 | 0.0 | $486,505 | $0 | $109,936 | Yes (X) | |||
| ARSHAD DESAI | |||||||||
| GROUP LEADER | 45.0 | 0.0 | Yes (X) | $529,700 | $0 | $53,700 | |||
| GEORGE COUKOS | |||||||||
| BRANCH DIRECTOR | 40.0 | 0.0 | $383,674 | $0 | $86,799 | Yes (X) | |||
| XIN LU | |||||||||
| BRANCH DIRECTOR | 50.0 | 0.0 | $366,682 | $0 | $48,226 | Yes (X) | |||
| Patrice Morin | |||||||||
| DEPUTY SCIENT. DIR. (SINCE AUG | 45.0 | 0.0 | $136,887 | $0 | $16,109 | Yes (X) | |||
| JOHN L NOTTER | |||||||||
| DIRECTOR, BOARD CHAIRPERSON | 8.0 | 3.0 | $27,259 | $123,876 | $0 | Yes (X) | |||
| JOHN D GORDAN III | |||||||||
| DIRECTOR | 2.0 | 2.0 | $10,384 | $78,876 | $0 | Yes (X) | |||
| DR NANCY ELLEN DAVIDSON | |||||||||
| DIRECTOR | 2.0 | 2.0 | $10,384 | $30,000 | $0 | Yes (X) | |||
| OLIVIER R E DUNANT | |||||||||
| DIRECTOR, VICE-CHAIR | 2.0 | 2.0 | $10,384 | $30,000 | $0 | Yes (X) | |||
| JUDGE BARBARA S JONES | |||||||||
| DIRECTOR | 2.0 | 2.0 | $10,384 | $30,000 | $0 | Yes (X) | |||
| ALEXANDRA JOHNSON | |||||||||
| DIRECTOR | 2.0 | 2.0 | $10,384 | $30,000 | $0 | Yes (X) | |||
| DR PHILIP A PIZZO | |||||||||
| DIRECTOR (to Aug. 2022) | 2.0 | 2.0 | $6,923 | $20,000 | $0 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $7,052,495 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $1,259,113 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $856,600 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 53 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|---|
| Barnes Thornburg LLP | ||||||||||
| 655 West Broadway Suite 1300 | SAN DIEGO | CA | 21101 | LEGAL SERVICES | $14,046,872 | |||||
| University of Lausanne | ||||||||||
| Research Services | $11,848,605 | BATIMENT UNICENTRE | LAUSANNE | 0 | SZ | CH-1015 | ||||
| Milbank LLP | ||||||||||
| 55 HUDSON YARDS | NEW YORK | NY | 100012163 | LEGAL SERVICES | $9,139,746 | |||||
| University of Oxford | ||||||||||
| Research Services | $9,012,004 | WELLINGTON SQUARE | OXFORD | 0 | UK | OX1 2JD | ||||
| Princeton University | ||||||||||
| 701 Carnegie Center | PRINCETON | NJ | 08540 | RESEARCH SERVICES | $8,398,720 | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 37 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $76,000,000 | RelatedOrganizationsAmt |
| Government Grants | $3,286,498 | GovernmentGrantsAmt |
| All Other Contributions | $11,416,083 | AllOtherContributionsAmt |
| Noncash Contributions | $1,487,498 | NoncashContributionsAmt |
| Total Contributions | $90,702,581 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,836 | TotalRevenueColumnAmt |
| Exclusion | $3,836 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,647,436 | TotalRevenueColumnAmt |
| Exclusion | $2,647,436 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Fundraising Direct Expenses | $0 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| REIMBURSEMENT OF INSURANCE COSTS | 900099 | $93,004 | $93,004 |
| REIMBURSEMENT FROM INSURANCE COMPANY | 900099 | $8,992,929 | $8,992,929 |
| VARIOUS COST RECOVERY | 900099 | $3,902 | $3,902 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $9,089,835 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $102,443,688 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $11,741,107 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,647,969 | TotalAmt |
| Program Services | $1,040,816 | ProgramServicesAmt |
| Management And General | $2,216,267 | ManagementAndGeneralAmt |
| Fundraising | $390,886 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,801,098 | TotalAmt |
| Program Services | $12,653,306 | ProgramServicesAmt |
| Management And General | $2,491,513 | ManagementAndGeneralAmt |
| Fundraising | $656,279 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,191,076 | TotalAmt |
| Program Services | $886,678 | ProgramServicesAmt |
| Management And General | $246,155 | ManagementAndGeneralAmt |
| Fundraising | $58,243 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,442,624 | TotalAmt |
| Program Services | $1,837,064 | ProgramServicesAmt |
| Management And General | $552,122 | ManagementAndGeneralAmt |
| Fundraising | $53,438 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,216,196 | TotalAmt |
| Program Services | $919,295 | ProgramServicesAmt |
| Management And General | $234,505 | ManagementAndGeneralAmt |
| Fundraising | $62,396 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,745,377 | TotalAmt |
| Program Services | $1,162,511 | ProgramServicesAmt |
| Management And General | $2,329,034 | ManagementAndGeneralAmt |
| Fundraising | $253,832 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,058,970 | TotalAmt |
| Program Services | $66,466 | ProgramServicesAmt |
| Management And General | $8,094,008 | ManagementAndGeneralAmt |
| Fundraising | $898,496 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $275,524 | TotalAmt |
| Management And General | $259,760 | ManagementAndGeneralAmt |
| Fundraising | $15,764 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,706,770 | TotalAmt |
| Program Services | $485,993 | ProgramServicesAmt |
| Management And General | $2,220,777 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $258,552 | TotalAmt |
| Program Services | $43,726 | ProgramServicesAmt |
| Management And General | $196,329 | ManagementAndGeneralAmt |
| Fundraising | $18,497 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $698,515 | TotalAmt |
| Program Services | $382,182 | ProgramServicesAmt |
| Management And General | $286,665 | ManagementAndGeneralAmt |
| Fundraising | $29,668 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $754,324 | TotalAmt |
| Program Services | $754,324 | ProgramServicesAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,624,436 | TotalAmt |
| Program Services | $2,794,686 | ProgramServicesAmt |
| Management And General | $742,349 | ManagementAndGeneralAmt |
| Fundraising | $87,401 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $354,843 | TotalAmt |
| Program Services | $106,522 | ProgramServicesAmt |
| Management And General | $224,037 | ManagementAndGeneralAmt |
| Fundraising | $24,284 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $30,427 | TotalAmt |
| Program Services | $22,297 | ProgramServicesAmt |
| Management And General | $7,648 | ManagementAndGeneralAmt |
| Fundraising | $482 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $688 | TotalAmt |
| Management And General | $619 | ManagementAndGeneralAmt |
| Fundraising | $69 | FundraisingAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $331,761 | TotalAmt |
| Program Services | $139,195 | ProgramServicesAmt |
| Management And General | $192,566 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| COLLABORATIVE PROGRAMS | $37,870,451 | $37,855,096 | $15,355 |
| OTHER SETTLEMENT FEES | $15,000,000 | $15,000,000 | |
| LABORATORY EXPENSES | $3,721,989 | $3,721,968 | $21 |
| CLINICAL TRIALS | $2,539,001 | $2,539,001 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,599,106 | TotalAmt |
| Program Services | $1,721,162 | ProgramServicesAmt |
| Management And General | $877,944 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $107,869,697 | TotalAmt |
| Program Services | $84,132,288 | ProgramServicesAmt |
| Management And General | $21,187,674 | ManagementAndGeneralAmt |
| Fundraising | $2,549,735 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,920,477 | BOYAmt |
| EOY | $11,132,200 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $302,627 | BOYAmt |
| EOY | $30,981 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,448,901 | BOYAmt |
| EOY | $912,965 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,817 | BOYAmt |
| EOY | $69,797 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $22,000 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $525,954 | BOYAmt |
| EOY | $523,554 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,231,092 | BOYAmt |
| EOY | $784,060 | EOYAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $33 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,549,662 | BOYAmt |
| EOY | $5,405,283 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,789,855 | BOYAmt |
| EOY | $2,724,867 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $25,811,385 | BOYAmt |
| EOY | $21,583,740 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,901,109 | BOYAmt |
| EOY | $15,643,897 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,634,901 | BOYAmt |
| EOY | $2,144,290 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,376,612 | BOYAmt |
| EOY | $1,765,522 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $21,912,622 | BOYAmt |
| EOY | $19,553,709 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Org Does Not Follow FASB117 | Yes (X) | OrgDoesNotFollowFASB117Ind |
Cap Stk Tr Prin Current Funds CapStkTrPrinCurrentFundsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $59,542 | BOYAmt |
| EOY | $59,542 | EOYAmt |
Pd In Cap Srpls Land Bldg Eqp Fund PdInCapSrplsLandBldgEqpFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rtn Earn Endowment Incm Oth Fnds RtnEarnEndowmentIncmOthFndsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,839,221 | BOYAmt |
| EOY | $1,970,489 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,898,763 | BOYAmt |
| EOY | $2,030,031 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $25,811,385 | BOYAmt |
| EOY | $21,583,740 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$5,426,009 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$144,346 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $3,701,623 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Other | Yes (X) | MethodOfAccountingOtherInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Organization | Yes (X) | MedicalResearchOrganizationInd |
Hospital Name And Address HospitalNameAndAddressGrp (9 entries)
| CityCityNm | CountryCountryCd | State AbbreviationStateAbbreviationCd |
|---|---|---|
| UNIVERSITY HOSPITAL CENTRE OF CANTON VAUD | ||
| Lausanne | SZ | |
| UNIVERSITY CLINIC OF ST LUC | ||
| Brussels | BE | |
| OXFORD UNIVERSITY HOSPITAL | ||
| Oxford | UK | |
| MEMORIAL SLOAN-KETTERING CANCER CENTER | ||
| New York | NY | |
| UNIVERSITY OF CALIFORNIA SCHOOL OF MEDICINE | ||
| San Diego | CA | |
| RWJ BARNABAS HEALTH | ||
| Princeton | NJ | |
| RUTGERS CANCER INSTITUTE OF NEW JERSEY | ||
| New Brunswick | NJ | |
| WEILL CORNELL MEDICAL COLLEGE | ||
| NEW YORK | NY | |
| JOHNS HOPKINS UNIVERSITY | ||
| BALTIMORE | MD | |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $107,869,697 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $107,869,697 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,000,000 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $250,000 | FilingOrganizationsTotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,000,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $1,000,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $1,000,000 | CurrentYearMinus1Amt |
| Current Year | $1,000,000 | CurrentYearAmt |
| Total | $4,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $250,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $250,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $250,000 | CurrentYearMinus1Amt |
| Current Year | $250,000 | CurrentYearAmt |
| Total | $1,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE C, PART II-A | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION MADE NO LOBBYING EXPENDITURES IN 2022. THEREFORE SCHEDULE C PART II-A, LINES 1A, 1B, 2C, AND 2F ARE ZERO. | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| CY Minus3 Yr Endwmt Fund | CYMinus3YrEndwmtFundGrp | |
| CY Minus4 Yr Endwmt Fund | CYMinus4YrEndwmtFundGrp | |
| Land | LandGrp | |
| Buildings | BuildingsGrp | |
| Leasehold Improvements | LeaseholdImprovementsGrp | |
| Equipment | EquipmentGrp | |
| Other Land Buildings | OtherLandBuildingsGrp | |
| Financial Derivatives | FinancialDerivativesGrp | |
| Closely Held Equity Interests | CloselyHeldEquityInterestsGrp |
Other Securities OtherSecuritiesGrp (7 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| UNIVERSE TANKSHIPS, INC, SHARE | $5,103,184 | C |
| VACCITECH ONCOLOGY LIMITED | $300,000 | C |
| LIFE SCIENCES PHARMA. INC., SH | $1,457 | C |
| RECEPTA INC., SHARES | $327 | C |
| ARIMA GENOMICS, INC | $210 | C |
| LUDWIG TECHNOLOGIES, INC SHARE | $100 | C |
| EPIGENOME TECHNOLOGIES, INC | $5 | C |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $5,405,283 | TotalBookValueSecuritiesAmt |
Other Assets Org OtherAssetsOrgGrp (5 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| PENSION PLAN 457B | $1,765,522 |
| DEPOSITS | $337,212 |
| EXPENSE ADVANCES STAFF | $10,476 |
| MISCELLANEOUS | $40,705 |
| Program cost to be refunded | $570,952 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $2,724,867 | TotalBookValueOtherAssetsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | PENSION PLAN 457B PAYABLE | Desc |
| Amt | $1,765,522 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $1,765,522 | TotalLiabilityAmt |
| Total Rev Etc Audited Fincl Stmt | $102,286,240 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$144,346 | NetUnrealizedGainsInvstAmt |
| Other Revenue | -$13,102 | OtherRevenueAmt |
| Revenue Not Reported | -$157,448 | RevenueNotReportedAmt |
| Revenue Subtotal | $102,443,688 | RevenueSubtotalAmt |
| Total Revenue Per Form990 | $102,443,688 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $108,098,834 | TotExpnsEtcAuditedFinclStmtAmt |
| Losses Reported | $229,137 | LossesReportedAmt |
| Expenses Not Reported | $229,137 | ExpensesNotReportedAmt |
| Expenses Subtotal | $107,869,697 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $107,869,697 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule D, Part XI, Line 2D | FormAndLineReferenceDesc |
| Explanation | Reversal of Prior Contribution | ExplanationTxt |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| Europe (Including Iceland and Greenland) | 3 | 28 | Program Services | Medical Research | $33,350,282 |
| East Asia and the Pacific | 0 | 6 | Program Services | Medical Research | $1,883,231 |
| Europe (Including Iceland and Greenland) | 1 | 51 | Program Services | Management | $2,952,647 |
| Russia and the Newly Independent States | 0 | 0 | Program Services | Medical Research | $169 |
| North America | 0 | 2 | Program Services | Medical Research | $109,427 |
| South America | 0 | 1 | Program Services | Medical Research | $51,290 |
| Europe (Including Iceland and Greenland) | 0 | 0 | Investments | $300,000 | |
| South America | 0 | 0 | Investments | $327 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 4 | SubtotalOfficesCnt |
| Subtotal Employees | 88 | SubtotalEmployeesCnt |
| Total Office | 4 | TotalOfficeCnt |
| Total Employee | 88 | TotalEmployeeCnt |
| Subtotal Spent | $38,647,373 | SubtotalSpentAmt |
| Total Spent | $38,647,373 | TotalSpentAmt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | FORM 990, SCHEDULE F, PART I, LINE 3 | FormAndLineReferenceDesc |
| Explanation | Refer to Schedule O Disclosure for Part IV, Line 12A and Part XII, Line 1. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (13 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EDWARD A MCDERMOTT JR | ||||||||||||||
| DIRECTOR, PRESIDENT | $0 | $916,361 | $0 | $0 | $0 | $0 | $0 | $61,572 | $0 | $39,898 | $0 | $1,017,831 | $0 | $0 |
| DR CHI VAN DANG | ||||||||||||||
| DIRECTOR, SCIENTIFIC DIRECTOR | $925,000 | $0 | $0 | $0 | $92,288 | $0 | $32,025 | $0 | $38,738 | $0 | $1,088,051 | $0 | $0 | $0 |
| JOHN L NOTTER | ||||||||||||||
| DIRECTOR, BOARD CHAIRPERSON | $27,259 | $123,876 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $27,259 | $123,876 | $0 | $0 |
| THOMAS BAENNINGER | ||||||||||||||
| CHIEF FINANCIAL OFFICER | $486,505 | $0 | $0 | $0 | $0 | $0 | $97,397 | $0 | $12,539 | $0 | $596,441 | $0 | $0 | $0 |
| DR JONATHAN SKIPPER | ||||||||||||||
| EXEC VICE-PRES TECH DEVELOP. | $704,480 | $0 | $0 | $0 | $62,425 | $0 | $32,025 | $0 | $39,852 | $0 | $838,782 | $0 | $0 | $0 |
| GEORGE COUKOS | ||||||||||||||
| BRANCH DIRECTOR | $383,674 | $0 | $0 | $0 | $0 | $0 | $82,644 | $0 | $4,155 | $0 | $470,473 | $0 | $0 | $0 |
| DR RICHARD KOLODNER | ||||||||||||||
| GROUP LEADER | $539,160 | $0 | $0 | $0 | $338,743 | $0 | $47,500 | $0 | $28,121 | $0 | $953,524 | $0 | $0 | $0 |
| DR RALPH VENHAUS | ||||||||||||||
| CHIEF MEDICAL OFFICER | $504,194 | $0 | $0 | $0 | $31,834 | $0 | $32,025 | $0 | $39,738 | $0 | $607,791 | $0 | $0 | $0 |
| DR DON CLEVELAND | ||||||||||||||
| GROUP LEADER | $759,480 | $0 | $0 | $0 | $380,738 | $0 | $43,500 | $0 | $27,735 | $0 | $1,211,453 | $0 | $0 | $0 |
| DR BING REN | ||||||||||||||
| GROUP LEADER | $466,026 | $0 | $0 | $0 | $258,577 | $0 | $47,500 | $0 | $31,601 | $0 | $803,704 | $0 | $0 | $0 |
| XIN LU | ||||||||||||||
| BRANCH DIRECTOR | $366,682 | $0 | $0 | $0 | $0 | $0 | $48,226 | $0 | $0 | $0 | $414,908 | $0 | $0 | $0 |
| ARSHAD DESAI | ||||||||||||||
| GROUP LEADER | $326,808 | $0 | $0 | $0 | $202,892 | $0 | $26,733 | $0 | $26,967 | $0 | $583,400 | $0 | $0 | $0 |
| Patrice Morin | ||||||||||||||
| DEPUTY SCIENT. DIR. (SINCE AUG | $137,500 | $0 | $0 | $0 | -$613 | $0 | $0 | $0 | $16,109 | $0 | $152,996 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule J, Part I, Line 3 | Edward A. McDermott Jr. is employed by the Ludwig Group, Inc. which provides management and administrative services to the Ludwig Institute for Cancer Research Ltd, LICR Fund, Inc., and other organizations. The Ludwig Institute is invoiced by the Ludwig Group, Inc. for the provision of services based on the time records maintained by the Ludwig Group, Inc. The total level of compensation for Edward A. McDermott Jr. which is paid by the Ludwig Group, Inc. under an employment agreement, is set and approved by the compensation committee of the Ludwig Institute. In setting the level of compensation, the Ludwig Institute's compensation committee arranges for an independent compensation survey. |
| Schedule J, Part I, Line 4a | For three individuals listed in Part II, other reportable compensation includes backpay and lost wages for the years 2020-2022. For one individual listed in Part II, other reportable compensation includes backpay and lost wages for the years 2020-2022, including a severance payment in connection with the dismissal of Cleveland et al. Ludwig Institute for Cancer Research, Case No. 19-cv-02141 and Case No.-cv-00871 (U.S. District Court, Southern District of California). |
| Schedule J, Part I, Line 4b | Edward A. McDermott Jr. participated in a supplemental non qualified retirement plan maintained by the Ludwig Group, Inc., a related organization of the Institute. The purpose of the Ludwig Group, Inc.'s supplemental pension plan is to provide certain supplemental benefits to certain select management or highly compensated employees who are participants in the employee pension plan of the Ludwig Group, Inc. All benefits payable under the plan, which is intended to constitute both an unfunded excess benefit plan under section 3(36) of title I of the employee retirement income security act of 1974, as amended, ("ERISA"), and a non qualified, unfunded deferred compensation plan for a select group of management or highly compensated employees under ERISA, are payable from the general assets of the Ludwig Group, Inc. The Ludwig Group, Inc. may establish and fund a trust in order to aid it in providing benefits due under the plan. Within the amount disclosed on Part VII, Section A, Line 1a, Column F, USD 51,322 is attributable to this plan for Edward A. McDermott Jr. |
| Schedule J, Part II, Column B | Column (B) includes compensation paid outside the U.S. to non-U.S. persons for which no Form W-2 or 1099-MISC has been issued. |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp | |
| Securities Publicly Traded | SecuritiesPubliclyTradedGrp | |
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | Services | Desc |
| Contribution | 3 | ContributionCnt |
| Noncash Contributions Rpt F990 | $1,487,498 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | Costs & Estimates | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule M, Part i | The organization is reporting the number of contributions received during the year. |
| Additional information to Part I, Line 25 | Consistent with the Financial Statements prepared in accordance with the Swiss Code of Obligations, the non-cash figure consists mainly of stipends and grants and related laboratory consumables received directly by staff working in the Ludwig Institute's laboratories for the benefit of the Ludwig Institute. The basis for valuation is, where possible, the actual amount received by the person concerned or, where this information is not available, a reasonable estimate of the person's stipend or grant etc. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (14 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part III - Statement of program service accomplishments | Line 4a - Laboratory Research leading to clinical applications The Ludwig Institute for Cancer Research Ltd was founded in 1971 as an international not-for-profit research institute dedicated to improving the understanding, prevention, detection and treatment of cancer. The Ludwig Institute's scientists conduct innovative basic research and facilitate the translation of promising discoveries related to cancer into applications for human benefit. Making meaningful advances that will ultimately transform care for cancer patients is central to the Ludwig Institute's mission. The Ludwig Institute engages leading scientists and clinicians in an integrated laboratory and clinical research effort to confront the global challenge of cancer. All laboratory research financed by the Ludwig Institute is carried out by its in-house research staff or through research collaborations involving Institute staff and external investigators. The Ludwig Institute has a staff of around 473 full time equivalents scientists, clinicians and support personnel as of December 31, 2022, located in four countries and focused on multiple aspects of cancer research. Approximately 80% of the total cost of the Ludwig Institute is funded by own resources. In addition to self-generated income from intellectual property, a significant amount is received from the LICR Fund, Inc., a Delaware supporting organization dedicated to maintaining an investment portfolio for this purpose. This funding setup gives Ludwig Institute investigators the freedom to tackle innovative long-term research and encourages and enables multidisciplinary teams of investigators to address significant and relatively complex challenges posed by cancer. The research activities of the Ludwig Institute, together with those of the Ludwig Centers established at six U.S. academic institutions with funding from a trust under the will of Daniel K. Ludwig are designated collectively as "Ludwig Cancer Research," an international community of distinguished scientists dedicated to studying cancer and advancing its prevention, diagnosis and treatment. The development, protection and licensing of intellectual property generated by research and technology development is fundamental to the Ludwig Institute's commitment to translate its discoveries for patient benefit. Income from these activities financed research expenditures amounting to USD 2.6 million in 2022. The Ludwig Institute also manages its IP and patents for public benefit. This means that the IP is made freely available to the academic research community. In 2022, Ludwig Institute Investigators published 228 primary research articles and 76 reviews, book chapters and commentaries. Progress was made in the study of tumor biology, cancer genomics, cancer prevention, the tumor micro-environment and tumor immunology. In 2022, 13 new U.S. patents and six new European patents were issued. Seven new U.S. applications and a further seven new international patent applications were also filed. |
| Form 990, Part III - Statement of program service accomplishments | Line 4B - Clinical Research The analysis of patient samples and evaluation of potential therapies in trials is essential to understanding cancer and exploring the therapeutic potential of new discoveries. Recognizing this, the Ludwig Institute takes responsibility for the discovery continuum from the laboratory to the early phase clinical trials. The Ludwig Institute believes that the same systematic investigative rigor that yielded the laboratory discovery in the first place should be applied in early-phase clinical trials to assess a discovery's therapeutic potential. Over the past few years, the Institute has moved away from centrally managed Ludwig-sponsored clinical trials overseen by a dedicated clinical trials management team in New York, in favor of having its clinical research implemented through locally sponsored, investigator-initiated clinical trials managed through its branch, collaborating institutions, or through non-profit clinical trial networks. The Ludwig Institute has licensing agreements with biotechnology and pharmaceutical companies that allow it to obtain proprietary investigational reagents and evaluate whether these agents might complement the therapeutic potential of the Ludwig Institute's own discoveries. The Ludwig Institute's interactions with industry are designed to protect its tax-exempt status to ensure that its discoveries are actively pursued as prognostic, diagnostic or therapeutic agents for human benefit. |
| Form 990, Part IV - Checklist of required schedules | Line 12A and Part XII - Financial statements and reporting, Line 1 The Ludwig Institute prepared consolidated financial statements in accordance with Swiss GAAP FER. The Ludwig Institute prepared statutory financial statements in accordance with the Swiss Code of Obligations. The Ludwig Institute prepared branch financial statements in accordance with the Swiss Code of Obligations for the following branches: Brussels (Belgium), Oxford (United Kingdom) and San Diego (United States). The submitted return 990 is based on the statutory financial statements in accordance with the Swiss code of Obligations. The following accounting principles apply: - Contributions are accounted for on the cash basis - Interest is accounted for on the accrual basis - External funding received from any outside source, whether of a cash or a non-cash nature is recorded in the Ludwig Institute's books of account on receipt. External funding received is taken to income when the corresponding expenditure is incurred. Any unspent income is deferred to future accounting periods. External funding pledged, but not received where expenditure has incurred, is taken into account as income and is accounted for as a grants receivable pending receipt. - License fees and royalties are accounted for on the modified cash basis. - Acquisition costs for research equipment, costs for leasehold improvements and costs for other assets are fully expensed in the year of acquisition. The Ludwig Institute prepared financial statements in accordance with office of management and budget circular A-133 for the San Diego branch (United States). The Ludwig Institute maintains accounting ledgers for the head office / administration and the research locations of Brussels, Oxford and San Diego. Accounting ledgers are maintained in USD. When any expenditure / income or balance sheet transactions are recorded in the accounts, a non-USD currency is converted into USD reporting currency using the monthly exchange rate of the transaction month as published by the Swiss federal tax administration. |
| Form 990, Part VI - Governance, management and disclosure | Section A - Governing body and management, Line 2 Edward A. McDermott Jr., director and officer of the Ludwig Institute for Cancer Research Ltd, and Dr. Jonathan Skipper, officer of the Ludwig Institute for Cancer Research Ltd, also serve as officers and board members of Ludwig Technologies, Inc. Each of the members of the board of directors of the Ludwig Institute is also a member of the board of directors of the LICR Fund, Inc. |
| Form 990, Part VI - Governance, management and disclosure | Section A - Governing body and management, Line 3 The Ludwig Group, Inc., a 100% subsidiary of the Ludwig Institute for Cancer Research Ltd, provides management and administrative services to the Ludwig Institute and related organizations, including personnel services and related facilities and equipment support, under formal service agreements with them. Edward A. McDermott Jr, director and president of the Ludwig Institute, is employed and compensated by the Ludwig Group, Inc. His compensation listed on the form 990, part VII is paid by the Ludwig Group, Inc. Edward A. McDermott Jr's services to Institute are billed to the Ludwig Institute by the Ludwig Group, Inc. |
| Form 990, Part VI - Governance, management and disclosure | Section A - Governing body and management, Line 6 The Ludwig Institute is organized as a Swiss not-for-profit organization. 49 of the shares are held by the trustees of the LICR Charitable trust, a Bermuda trust recognized by the IRS as an exempt supporting organization of the Ludwig Institute under section 501(c)(3) and 509(a)(3) of the Internal Revenue Code, whose primary purpose is to administer, devote and apply its assets to further the charitable purposes of the Ludwig Institute. Pursuant to the provisions of the Ludwig Institute's statutes, the members of the board of directors are no longer required to be shareholders. Three of the trustees of the LICR Charitable Trust are members of the Institute board of directors. One of the three trustees of the LICR Charitable Trust is also an officer of the Ludwig Institute. One share is held by the Swiss confederation. |
| Form 990, Part VI - Governance, Management and disclosure | Section A - Governing body and management, Line 7a The statutes of the Ludwig Institute confer on its shareholders the authority to elect and remove members of the board of directors and participate in proceedings, deliberations elections and votes at shareholder meetings. The shares do not confer proprietary rights or any entitlement to any share of the Ludwig Institute's net income or capital or any other asset owned or managed by the Ludwig Institute. The Ludwig Institute's statutes prohibit the payment of any dividends or distribution of income or capital to the shareholders. |
| Form 990, Part VI - Governance, management and disclosure | Section A - Governing body and management, Line 7b The shareholders have the power to grant discharge to the members of the board of directors and the executive officers at the shareholders' annual meeting for their conduct of business. The annual financial statements are submitted to the shareholders by the board of directors for shareholder approval. The shareholders have the right to make resolutions in respect of mergers, dissolutions or liquidation of the company and of any change of the company's registered office. |
| Form 990, Part VI - Governance, management and disclosure | Section B - Policies, Line 11B The Ludwig Institute's form 990 is reviewed at several levels. The Ludwig Institute's Zurich office senior staff, the vice president, finance, located in New York and external tax counsel review the draft form 990. Following these reviews, the chairperson of the audit committee and the president of the Ludwig Institute review the draft return prior to presenting it to the audit committee for further review. The final draft of form 990 is then presented to the Ludwig Institute's board of directors prior to its submission to the Internal Revenue Service. |
| Form 990, Part VI - Governance, management and disclosure | Section B - Policies, Line 12c The Ludwig Institute has two conflict of interest policies - one for the Board of Directors, Officers and Key Employees, and one for staff. Annually all members of the Board of Directors, Officers, Key Employees and staff are required to disclose any conflicts of interest. Board members and executive officers complete a conflict of interest questionnaire. All other staff members complete a confidential disclosure form. The completed questionnaires of the members of the board of directors and executive officers are reviewed by the compliance and risk officer. Those containing any disclosures or potential conflicts of interest are referred to the chairperson of the audit committee and, if appropriate, to the audit committee. At the same time it is confirmed to the audit committee chairperson that the other individuals had not reported any disclosures or potential conflicts of interest. Following this annual disclosure, if a conflict of interest is subsequently deemed to exist, it is the duty of the individual with the conflict to disclose it. For all cases where a conflict of interest exists, the matter is recorded in the minutes of the meeting of the audit committee or the board. Where the conflict concerns any board or committee member the individual(s) is (are) not permitted to participate in any vote or deliberation on the matter nor be counted in determining the existence of a quorum for the purposes of any action of the board or committee considering the matter. The annual disclosures by staff are reviewed by senior management and escalated as necessary. In addition, during the year, prior to involvement in activities that could be a potential or perceived conflict or interest, individuals are required to provide a written description of such activities to a committee of disinterested officers. Activities determined to be a conflict of interest that are not manageable may not be undertaken by the individual. For activities determined to be a conflict of interest that are manageable, details will be submitted to the audit committee of the Institute board of directors for approval. |
| Form 990, Part VI - Governance, management and disclosure | Section B - Policies, Line 15 The compensation of the members of the board of directors, the executive officers and former directors and officers who are retained as employees or consultants of the Ludwig Institute is subject to review by the Ludwig Institute's compensation committee, which consists of independent members of the board. The compensation reviewed includes the compensation of the chief executive officer, Edward A. McDermott Jr., who is employed by Ludwig Group, Inc., which provides management services to the Ludwig Institute. Independent compensation consultants provide comparability surveys to the committee. Organizations selected for peer analysis in the comparability surveys are intended to capture competitor organizations of similar size, revenue /operating budget and industry relevance to the Ludwig Institute. The studies last took place in Fall 2021 and are conducted approximately every three years. Minutes of the review and decisions made by the compensation committee are kept and, once approved by the committee at a subsequent meeting, are signed by the chairperson and the secretary to the board. The compensation committee's decisions are reported to the board of directors and recorded in the minutes of the board meetings, which are kept for all board meetings. Once approved by the board at a subsequent meeting, the minutes of meetings are signed by the chairperson and the secretary to the board. |
| Form 990, Part VI - Governance, management and disclosure | Section C - Disclosure, Line 19 The annual research highlights, the annual financial reports and the governing documents are available on the website www.ludwigcancerresearch.org under Disclosures and on request at the administrative offices in New York and Zurich, Switzerland. |
| Form 990, Part VII - Compensation of officers, directors, key employees | Section A - Officers, directors, trustees, key employees and highest compensated employees, Line 1a As part of the annual preparation of the form 990, all board of directors and executive officers provide an estimate of hours worked for the Ludwig Institute and the related organizations (see part VII for hours devoted to related organizations). The related organizations report the respective compensation figures to the Ludwig Institute and provide copies of the submitted W-2 returns / 1099 returns. |
| Form 990, Part XI - Reconciliation of net assets, Line 9 | Other changes in net assets Net loss on foreign exchange due to operations $ (1,059,658) Net foreign exchange gain on capital and reserve $ 830,521 Extraordinary income due to release of tax provision $ 3,943,862 Reversal of Prior Contribution $ (13,102) ------------ Net gain $ 3,701,623 |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| LICR Fund Inc | ||||||||||
| 600 Third Avenue 32nd Floor | New York | NY | 10016 | 133573053 | See Part VII | DE | 501(C)(3) | 12A - I | Ludwig Inst | Yes (true) |
| LICR Charitable Trust | ||||||||||
| 600 Third Avenue 32nd Floor | New York | NY | 10016 | 986039547 | See Part VII | NY | 501(C)(3) | 12B - II | None | false |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (3 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Entity TypeEntityTypeTxt | Share Of Total IncomeShareOfTotalIncomeAmt | Share Of EOY AssetsShareOfEOYAssetsAmt | OwnershipOwnershipPct | Controlled OrganizationControlledOrganizationInd | Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Legal Domicile StateLegalDomicileStateCd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Universe Tankships Inc UTI | |||||||||||||||||
| Trust Complex Ajeltake IS Ajeltak | Rd Majuro | RM | MH96960 | 131603827 | Holding | RM | Ludwig Inst | C Corp | $8,695,361 | $26,343,344 | 1.00000 | Yes (true) | |||||
| The Ludwig Group Inc | |||||||||||||||||
| 132808920 | Admin service | UTI | C Corp | $9,476,124 | $16,899,291 | 1.00000 | Yes (true) | 600 Third Avenue 32nd Floor | New York | NY | 10016 | DE | |||||
| Ludwig Technologies Inc | |||||||||||||||||
| 273166967 | Holding Co | Ludwig Inst | C Corp | $0 | $516 | 1.00000 | Yes (true) | 600 Third Avenue 32nd Floor | New York | NY | 10016 | DE | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (true) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (true) | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (5 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| LICR Fund Inc | ||
| c | $76,000,000 | CASH |
| The Ludwig Group Inc | ||
| m | $2,464,020 | INVOICE AMOUNTS |
| The Ludwig Group Inc | ||
| n | $1,236,807 | INVOICE AMOUNTS |
| The Ludwig Group Inc | ||
| p | $1,641,596 | INVOICE AMOUNTS |
| LICR Fund Inc | ||
| q | $55,802 | INVOICE AMOUNTS |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Part II, Column 2B - Description of main activity related tax exempt org | FormAndLineReferenceDesc |
| Explanation | Tax exempt organizations LICR Fund, Inc. is a Delaware not-for-profit corporation and a supporting organization of the Ludwig Institute, which provides financial support for the Ludwig Institute's conduct of medical research activities. LICR Charitable Trust is a Bermudian trust whose mission is to maintain oversight and control of the management of the Ludwig Institute, including election of the Institute's board of directors. | ExplanationTxt |
Comments